Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Semaglutide recalled?

Yes — there is an active recall. 47 ongoing FDA recalls mention Semaglutide (54 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Semaglutide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Semaglutide recalls on record

none so far in 2026; 54 on record, newest first
Class II · Moderate risk

OZEMPIC (semaglutide)

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-4132-90 D-0617-2021
Class II · Moderate risk

Rybelsus (semaglutide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0169-4307-13 D-0536-2021